Nocturnal hypoxemic burden during positive airway pressure treatment across different central sleep apnea etiologies
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Nocturnal hypoxemic burden during positive airway pressure treatment across different central sleep apnea etiologies. / Linz, Dominik; Malfertheiner, Maximilian Valentin; Werner, Nils; Lerzer, Christoph; Gfüllner, Florian; Linz, Benedikt; Zeman, Florian; McEvoy, R. Doug; Arzt, Michael; Baumert, Mathias.
I: Sleep Medicine, Bind 79, 2021, s. 62-70.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nocturnal hypoxemic burden during positive airway pressure treatment across different central sleep apnea etiologies
AU - Linz, Dominik
AU - Malfertheiner, Maximilian Valentin
AU - Werner, Nils
AU - Lerzer, Christoph
AU - Gfüllner, Florian
AU - Linz, Benedikt
AU - Zeman, Florian
AU - McEvoy, R. Doug
AU - Arzt, Michael
AU - Baumert, Mathias
N1 - Publisher Copyright: © 2021 Elsevier B.V.
PY - 2021
Y1 - 2021
N2 - Introduction: Nocturnal hypoxemia is associated with increased cardiovascular mortality. Here, we assess whether positive airway pressure by adaptive servo-ventilation (ASV) reduces nocturnal hypoxemic burden in patients with primary central sleep apnea (primary CSA), or heart failure related central sleep apnea (CSA-HF) and treatment emergent central sleep apnea (TECSA). Methods: Overnight oximetry data from 328 consecutive patients who underwent ASV initiation between March 2010 and May 2018 were retrospectively analyzed. Patients were stratified into three groups: primary CSA (n = 14), CSA-HF (n = 31), TECSA (n = 129). Apnea hypopnea index (AHI) and time spent below 90% SpO2 (T90) was measured. Additionally, T90 due to acute episodic desaturations (T90Desaturation) and due to non-specific and non-cyclic drifts of SpO2 (T90Non-specific) were assessed. Results: ASV reduced the AHI below 15/h in all groups. ASV treatment significantly shortened T90 in all three etiologies to a similar extent. T90Desaturation, but not T90Non-specific, was reduced by ASV across all three patient groups. AHI was identified as an independent modulator for ΔT90Desaturation upon ASV treatment (B (95% CI: −1.32 (−1.73; −0.91), p < 0.001), but not for ΔT90 or ΔT90Non-specific. Body mass index was one independent predictor of T90. Conclusions: Across different central sleep apnea etiologies, ASV reduced AHI, but nocturnal hypoxemic burden remained high due to a non-specific component of T90 not related to episodic desaturation. Whether adjunct risk factor management such as weight-loss can further reduce T90 warrants further study.
AB - Introduction: Nocturnal hypoxemia is associated with increased cardiovascular mortality. Here, we assess whether positive airway pressure by adaptive servo-ventilation (ASV) reduces nocturnal hypoxemic burden in patients with primary central sleep apnea (primary CSA), or heart failure related central sleep apnea (CSA-HF) and treatment emergent central sleep apnea (TECSA). Methods: Overnight oximetry data from 328 consecutive patients who underwent ASV initiation between March 2010 and May 2018 were retrospectively analyzed. Patients were stratified into three groups: primary CSA (n = 14), CSA-HF (n = 31), TECSA (n = 129). Apnea hypopnea index (AHI) and time spent below 90% SpO2 (T90) was measured. Additionally, T90 due to acute episodic desaturations (T90Desaturation) and due to non-specific and non-cyclic drifts of SpO2 (T90Non-specific) were assessed. Results: ASV reduced the AHI below 15/h in all groups. ASV treatment significantly shortened T90 in all three etiologies to a similar extent. T90Desaturation, but not T90Non-specific, was reduced by ASV across all three patient groups. AHI was identified as an independent modulator for ΔT90Desaturation upon ASV treatment (B (95% CI: −1.32 (−1.73; −0.91), p < 0.001), but not for ΔT90 or ΔT90Non-specific. Body mass index was one independent predictor of T90. Conclusions: Across different central sleep apnea etiologies, ASV reduced AHI, but nocturnal hypoxemic burden remained high due to a non-specific component of T90 not related to episodic desaturation. Whether adjunct risk factor management such as weight-loss can further reduce T90 warrants further study.
KW - Adaptive servo-ventilation
KW - Continuous positive airway pressure
KW - Heart failure
KW - Oximetry
KW - Sleep apnea
KW - Sleep-disordered breathing
U2 - 10.1016/j.sleep.2021.01.007
DO - 10.1016/j.sleep.2021.01.007
M3 - Journal article
C2 - 33482454
AN - SCOPUS:85099610301
VL - 79
SP - 62
EP - 70
JO - Sleep Medicine
JF - Sleep Medicine
SN - 1389-9457
ER -
ID: 279885809